MoonLake Immunotherapeutics Research And Development Expense

• MoonLake Immunotherapeutics showed an increase of +79.9% in Research And Development Expense from 2024 to 2025.
• This data is from MoonLake Immunotherapeutics's annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 4 years of available data (2022 to 2025), MoonLake Immunotherapeutics's Research And Development Expense has grown by 382.4%.
• Historical annual values: Fiscal year 2025: $202.86 million | Fiscal year 2024: $112.77 million | Fiscal year 2023: $31.80 million | Fiscal year 2022: $42.05 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026